China Resources Pharmaceutical Group Ltd (3320)

Hong Kong
Currency in HKD
5.26
-0.02(-0.38%)
Closed
3320 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
High dividend Yield
Fair Value
Day's Range
5.255.33
52 wk Range
4.627.11
Key Statistics
Edit
Bid/Ask
5.25 / 5.24
Prev. Close
5.26
Open
5.28
Day's Range
5.25-5.33
52 wk Range
4.62-7.11
Volume
7.11M
Average Volume (3m)
7.96M
1-Year Change
3.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3320 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.21
Upside
+37.12%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

China Resources Pharma Company Profile

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and v, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.

Employees
72764
Market
Hong Kong

Compare 3320 to Peers and Sector

Metrics to compare
3320
Peers
Sector
Relationship
P/E Ratio
8.2x14.9x−0.6x
PEG Ratio
0.800.260.00
Price/Book
0.6x1.6x2.6x
Price / LTM Sales
0.1x1.9x3.1x
Upside (Analyst Target)
32.5%42.9%48.2%
Fair Value Upside
Unlock22.1%8.0%Unlock

Analyst Ratings

10 Buy
2 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.21
(+37.12% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.601
Dividend Yield
4.95%
Industry Median 2.75%
Annualised payout
0.2605
Paid unevenly
5-Years Growth
+14.39%
Growth Streak

Earnings

Latest Release
May 29, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the China Resources Pharma (3320) Stock Price Today?

The China Resources Pharma stock price today is 5.26.

What Stock Exchange Does China Resources Pharma Trade On?

China Resources Pharma is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for China Resources Pharma?

The stock symbol for China Resources Pharma is "3320."

Does China Resources Pharma Pay Dividends? What’s The Current Dividend Yield?

The China Resources Pharma dividend yield is 4.95%.

What Is the China Resources Pharma Market Cap?

As of today, China Resources Pharma market cap is 33.05B.

What is China Resources Pharma Earnings Per Share?

The China Resources Pharma EPS is 0.601.

From a Technical Analysis Perspective, Is 3320 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.